ダウンロード数: 162

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
oncotarget.23536.pdf1.11 MBAdobe PDF見る/開く
タイトル: An integrated analysis of hyponatremia in cancer patients receiving platinum-based or nonplatinum-based chemotherapy in clinical trials (JCOG1405-A)
著者: Ezoe, Yasumasa
Mizusawa, Junki
Katayama, Hiroshi
Kataoka, Kozo
Muto, Manabu  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-3127-8203 (unconfirmed)
著者名の別形: 武藤, 学
キーワード: hyponatremia
platinum agent
cisplatin
carboplatin
risk factors
発行日: 2018
出版者: Impact Journals LLC
誌名: Oncotarget
巻: 9
号: 5
開始ページ: 6595
終了ページ: 6606
抄録: Background: Hyponatremia is a common electrolyte abnormality in cancer patients who receive chemotherapy. Among anticancer agents, platinum-based agents are reported to cause chemotherapy-induced hyponatremia. However, the actual incidence and risk factors remain unknown. Results: The reports of 29 trials were analyzed. The incidence of grade 3/4 hyponatremia was 11.9% in patients treated with platinum-based chemotherapy and 3.8% in those treated with nonplatinum-based regimens (P < 0.01). Univariable analysis revealed a high incidence of hyponatremia in patients receiving cisplatin, three-drug combination regimen, two-drug combination regimen with amrubicin or irinotecan, or high-dose cisplatin (weekly equivalent cisplatin dose ≥20 mg/m²), and in patients with small-cell lung cancer. Conclusion: This is the first report of the actual incidence and the potential risk factors of chemotherapy-induced hyponatremia. Careful monitoring of serum sodium level is needed when platinum-based chemotherapy is administered. Methods: This study included all clinical trials of systemic chemotherapies for solid cancers that were conducted by the Japan Clinical Oncology Group (JCOG) after January 2000 and of which the patient enrolment was completed by January 2014. The latest reports of each trial were used for analysis. The incidence of chemotherapy-induced grade 3/4 hyponatremia and the potential risk factors were investigated with univariable analysis.
著作権等: Copyright: Ezoe et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
URI: http://hdl.handle.net/2433/255285
DOI(出版社版): 10.18632/oncotarget.23536
PubMed ID: 29464095
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。